Document is current
Any future updates will be listed below
-
Authors
Chen, Ruijue
Chen, Qiying
Wang, Ying
Feng, Zhiyang
Xu, ZiWei
Zhou, Pei
Huang, Wenyi
Cheng, Hao
Li, Lijun
Feng, Jun
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Guangxi Province (2016GXNSFAA380108, 2020GXNSFAA297168)
National Natural Science Foundation of China (81860633, 82260701)
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (CMEMR2019-B10)
- License Information
-
More Information
Article History
Received: 13 December 2022
Revised: 13 February 2023
Accepted: 16 February 2023
First Online: 17 March 2023
Declarations
:
: Human serum was provided by Shanghai Tongwei Bio-Tech Co. for scientific use only. The human serum samples used in this paper were only mock samples obtained by artificial addition of analytes (chlorpromazine hydrochloride and aminophylline) to blank serum, and no blood samples from clinical patients were used directly. Therefore, the ethics committee did not have to approve this study.
: The authors declare no competing interests.
